Tag: Blood Glucose Monitors
Low-Glucose Alerts Beneficial for Insulin-Treated Drivers With Diabetes
Low-glucose alerts improve time below range for drivers with T1D and reduce incidence of low glucose for all insulin-treated drivers
Continuous Glucose Monitors Overestimate Glycemic Responses
Variation in CGM bias by postprandial test, with glycemic index for commercial fruit smoothie higher with CGM versus capillary sampling
Study Explores Effect of Hybrid Closed-Loop Therapy on Diabetic Complications
Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis
Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices
Hardware and software changes, updates, and configurations can result in undelivered critical safety alerts
Continuous Glucose Monitoring Can Predict Microvascular Complications in Type 1 Diabetes
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data
FDA Expands Approval of Omnipod 5 Insulin Delivery System to Include Patients With Type...
Omnipod 5 works in concert with a continuous glucose monitor to manage blood glucose with no daily injections and no finger pricks
First OTC Continuous Blood Glucose Monitor Cleared for Marketing by FDA
Dexcom Stelo Glucose Biosensor System is intended for people aged 18 years and older who have T2D but do not take insulin
FDA Warns of Smartwatches That Claim to Measure Glucose Levels
Many companies are illegally marketing smartwatch or smart ring devices that claim to measure blood glucose without piercing the skin
Not Even Private Health Insurance Overcomes Racial Disparities in Glycemic Control
Worse glycemic control seen for Hispanic and Black adults
Decision Support Tool Cuts Hypoglycemia Risk in Older Adults
Decreased use of insulin and sulfonylureas seen postintervention
